We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

Fund managers haven’t disclosed any holdings of LOXO yet.

LOXO Hedge Fund Activity: Q2 2019 in Review

0 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q2 2019, worth a combined $0 — down 100% from $65K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of LOXO and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Itau Unibanco Holding S.A., exiting entirely with an estimated $65K sold.

  • 0 institutional investors held Loxo Oncology, Inc (LOXO) as of Q2 2019, down from 1 in Q1 2019.
  • Funds reported $0 of Loxo Oncology, Inc stock for Q2 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Loxo Oncology, Inc positions in Q2 2019 and 1 closed out, a net change of -1 holder.
  • The largest Loxo Oncology, Inc seller in Q2 2019 was Itau Unibanco Holding S.A., an estimated $65K sold.

Based on aggregated 13F filings for Q2 2019.